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United Kingdomc; Microbiology Department, Moyne Institute of Preventative Medicine, Trinity College Dublin, Dublin, Irelandd
The capacity for intracellular survival within phagocytes is likely a critical factor facilitating the dissemination of Staphylococcus
aureus in the host. To date, the majority of work on S. aureus-phagocyte interactions has focused on neutrophils and, to a lesser
extent, macrophages, yet we understand little about the role played by dendritic cells (DCs) in the direct killing of this bacte-
rium. Using bone marrow-derived DCs (BMDCs), we demonstrate for the first time that DCs can effectively kill S. aureus but
that certain strains of S. aureus have the capacity to evade DC (and macrophage) killing by manipulation of autophagic path-
ways. Strains with high levels of Agr activity were capable of causing autophagosome accumulation, were not killed by BMDCs,
and subsequently escaped from the phagocyte, exerting significant cytotoxic effects. Conversely, strains that exhibited low levels
of Agr activity failed to accumulate autophagosomes and were killed by BMDCs. Inhibition of the autophagic pathway by treat-
ment with 3-methyladenine restored the bactericidal effects of BMDCs. Using an in vivomodel of systemic infection, we demon-
strated that the ability of S. aureus strains to evade phagocytic cell killing and to survive temporarily within phagocytes corre-
lated with persistence in the periphery and that this effect is critically Agr dependent. Taken together, our data suggest that
strains of S. aureus exhibiting high levels of Agr activity are capable of blocking autophagic flux, leading to the accumulation of
autophagosomes. Within these autophagosomes, the bacteria are protected from phagocytic killing, thus providing an intracel-
lular survival niche within professional phagocytes, which ultimately facilitates dissemination.
Staphylococcus aureus causes a wide range of pathologies fromsuperficial skin infections to more serious invasive infections
associated with significant morbidity and mortality. In severe
cases, localized infections can lead to bacterial invasion of the
vascular system, causing life-threatening conditions such as bac-
teremia and sepsis. A key factor facilitating this dissemination is
the impressive arsenal of immune evasion strategies available to S.
aureus that enables it to evade recognition and killing by the host
immune system (1). Identifying and disarming the mechanisms
bywhich this organism circumvents the host’s immune system are
important strategies for identifying novel therapies.
Although classically considered an extracellular bacterium, S.
aureus is capable of invading and persisting within a variety of
nonprofessional phagocytic host cells (2), facilitating tissue per-
sistence and relapsing disease. Strikingly, this organism is also ca-
pable of manipulating professional phagocytes, and there is evi-
dence that S. aureus can survive within monocytes, macrophages,
and even neutrophils (3–6). Unlike resident tissue cells, profes-
sional phagocytes aremobile and represent an opportunity for the
bacterium to disseminate from the primary focus of infection to
systemic sites. In a mechanism similar to that employed by tradi-
tional intracellular bacteria such as Mycobacterium tuberculosis
and Listeria monocytogenes, which utilize monocytes to dissemi-
nate via the bloodstream (7, 8), it has been proposed that S. aureus
may be capable of subverting neutrophils to facilitate its dissemi-
nation (9). S. aureus has also been shown to persist within human
monocyte-derived macrophages (3), suggesting that these cells
may also provide a potential intracellular niche to facilitate S. au-
reus dissemination in vivo. The bulk of the research conducted
into the survival of S. aureus within or killing of S. aureus by
phagocytes has focused on neutrophils and, to a lesser extent,
macrophages. To date, the contribution of dendritic cells (DCs) to
the direct killing of S. aureus and the capacity of S. aureus to ma-
nipulate these particular phagocytes have not been explored.
Despite the fact that the environment inside phagocytes is less
thanhospitable, gaining an intracellular niche, even briefly,within
these cells affords a window of opportunity for extended survival
and potential dissemination. Critical to survival is the ability to
avoid destruction within phagolysosomes, and S. aureus is
equipped with a number of strategies to resist phagolysosomal
killing (10–12). Having circumvented these killing mechanisms,
the bacterium can then escape into the cytoplasm, which, in most
cases, eventually leads to host cell death, releasing the bacteria into
the extracellular space, where they have the opportunity to repli-
cate and infect other host cells. Phagosomal escape by S. aureushas
been shown to depend upon the regulatory system encoded by the
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agr locus (3, 13, 14), which controls the expression of a number of
virulence factors, including the secreted toxin alpha-hemolysin
(Hla), a critical effector molecule essential for S. aureus survival
within macrophages (3). Phenol-soluble modulins (PSMs) are
small cytotoxic alpha-helical peptides. They are categorized into
two classes, PSM and PSM peptides. PSM peptides are regu-
lated by the Agr system and enable phagosomal escape of S. aureus
from both nonprofessional (15) and professional (16, 17) phago-
cytes. Survival within neutrophils appears to be dependent upon
the accessory regulator SarA, which facilitates the survival of S.
aureus within large vacuoles that are not competent for fusion
with lysosomes (5). While it is clear that phagocytes are critically
important for effective clearance of S. aureus during an infection,
it may be that the intracellular locale of the bacterium postphago-
cytosis will dictate whether or not the phagocytes contribute to
host protection or inadvertently play a deleterious role.
Autophagy is an important homeostatic process in eukaryotic
cells that is critical for cell survival. Damaged cytosolic compo-
nents are removed and recycled in double-membrane vacuoles,
called autophagosomes, that are characterized by the recruitment
of microtubule-associated protein 1 light chain 3 (LC3) conju-
gated to phosphatidylethanolamine (LC3-II) to their membrane
(18). These autophagosomes then fuse with lysosomes and are
digested. This process of autophagosome formation and eventual
degradation is termed autophagic flux (19). Autophagy also plays
an important role in host defense against bacteria that can invade
host cells, such as Streptococcus pyogenes (20), or facultative intra-
cellular pathogens, such asMycobacterium tuberculosis (21). These
organisms are sequestered in autophagosomes, which then deliver
the bacteria to the lysosomes for destruction. Some microorgan-
isms (e.g., Coxiella burnetii and Porphyromonas gingivalis) have
evolved mechanisms to subvert the autophagic machinery of the
cell, delaying autophagosomal maturation and lysosomal fusion
and thus creating a survival niche within autophagosomes (22). S.
aureus can localize to autophagosomes and inhibit lysosomal fu-
sion within HeLa cells, while proliferation of S. aureus was im-
paired within fibroblasts deficient in the autophagy protein Atg5
(23), indicating an essential role for the autophagy pathway in
facilitating the intracellular survival of S. aureus within nonpro-
fessional phagocytic cells. In this study, a strain that expresses low
levels of agr failed to colocalize with autophagosomal markers,
identifying the requirement for Agr-regulated genes to engage au-
tophagosomes.
Whether or not S. aureus can manipulate the autophagic pro-
cess in professional phagocytes as ameans to evade killing remains
to be established. We hypothesized that subversion of autophagy
in professional phagocytes could provide S. aureus a means to
preserve a temporary intracellular survival niche, in order to facil-
itate dissemination. We demonstrate the strain-dependent ability
of S. aureus to induce the accumulation of autophagosomes in
phagocytes, which appears to correlatewith interstrain differences
in Agr expression. Strains with high levels of Agr activity became
associated with autophagosomes, were not killed by phagocytic
cells in vitro, and demonstrated extended intracellular survival
within phagocytes in vivo.
MATERIALS AND METHODS
Bacterial strains. S. aureus strains SH1000 (clonal complex 8 [CC8]) and
PS80 (CC30) were described previously (24, 25). S. aureus clinical isolates
were obtained from blood culture bottles of patients diagnosed with S.
aureus bacteremia at St George’s Healthcare NHS Trust, London, United
Kingdom. Two isolates were used repeatedly throughout this study: Sa68
and Sa279. Both of these strains aremethicillin sensitive and belong to the
CC1 lineage.
The expression of enhanced green fluorescent protein (GFP) (26) in
the PS80 background was achieved through the integration of a nonrep-
licative integrase vector (pIMC11-GFP) into the phage 11 attachment site.
Expression of enhancedGFP is under the control of the Pxyl/tetO promoter,
without repression from TetR. Chromosomal integration of PS80::
pIMC11-GFP was validated with oligonucleotides IM293 and IM294,
which amplify across the site of integration, yielding a 0.7-kb product in
PS80 and a 3.4-kb product in PS80::pIMC11-GFP.
Deletion of the agr locus (agrBDCA genes) within PS80 was achieved
by allelic exchange using pIMAY (27). Primers agr1 and agr2 amplified
532 bp ofDNAupstreamof agrB, and primers agr3 and agr4 amplified 535
bp of DNA located downstream of the agrA gene (Table 1). The PCR
products were denatured and allowed to reanneal via the complementary
sequences in primers agr2 and agr3. This was used as the template for PCR
using primers agr1 and agr4. The amplimer was cloned into pIMAY (27)
between the SalI and EcoRI restriction sites by using sequence- and ligase-
independent cloning (28), and the resulting plasmid (pIMAY::agr) was
transformed into DC10B cells and verified by DNA sequencing. The plas-
mid was transformed into electrocompetent PS80 cells, and deletion of
the agr genes was achieved by allelic exchange, as previously described
(27). The deletion was confirmed byDNA sequencing of a PCR amplimer
generated by using PS80agr genomic DNA as the template and primers
agr OUT F and agr OUT R. The mutant did not produce delta-hemolysin
on sheep blood agar.
All bacteria were cultivated from frozen stocks for 24 h at 37°C on agar
plates. Bacterial suspensions were then prepared in phosphate-buffered
saline (PBS), and the concentrations were estimated by measuring the
absorbance of the suspension at 600 nm. CFUwere determined by plating
serial dilutions of each inoculum.
In the case of PS80-GFP, log-phase growth was required for op-
timal GFP expression. A single colony was inoculated into tryptic soy
broth (TSB) overnight, and a subculture in fresh TSB was taken the fol-
lowing morning. The concentration of bacteria in the broth was deter-
mined by measuring the absorbance at 600 nm and confirmed by streak-
ing on agar plates.
For immunofluorescence analysis, bacteria were stained with Cell
Trace Violet (CTV; Life Technologies). Stationary-phase bacteria in PBS
at the appropriate optical density (OD) were incubated with CTV for 20
min at 37°C with rotation. The bacteria were then washed and resus-
pended in PBS prior to infection of cells.
Animals.Groups ofwild-typeC57BL/6mice (6 to 8weeks of age)were
housed under specific-pathogen-free (SPF) conditions at the Trinity Col-
lege Dublin Comparative Medicines facility. All animal experiments were
conducted in accordancewith the recommendations and guidelines of the
Health Products Regulatory Authority (HPRA), the competent authority
TABLE 1 Primers used in mutation of PS80
Primer Sequence
IM293 TATACCTCGATGATGTGCATAC
IM294 GCTGATCTAACAATCCAATCCA
agr1 CCTCACTAAAGGGAACAAAAGCTGGGTACCACTCTA
CTAGCAAATGTTACTC
agr2 CAAACTGGTCAATTTTGTTATC
agr3 CACATCGGTTGCTAAAATCCTTAATAAGATAATAAA
GTCAGTTAAC
agr4 CGACTCACTATAGGGCGAATTGGAGCTCAGGATTTT
AGCAACCGATGTG
agr OUT F AATACATAGCACTGAGTCCAAG
agr OUT R GGGATGCCTTTATTGGTGCAG
O’Keeffe et al.
3446 iai.asm.org September 2015 Volume 83 Number 9Infection and Immunity
 o
n
 February 28, 2018 by University of Bristol Inform
ation Services
http://iai.asm
.org/
D
ow
nloaded from
 
in Ireland, and in accordance with protocols approved by the Trinity
College Animal Research Ethics Committee.
Cell culture. Bone marrow-derived dendritic cells (BMDCs) were
prepared by culturing bone marrow cells isolated from C57BL/6 mice
with granulocyte-macrophage colony-stimulating factor (GM-CSF), as
described previously (29). On day 10, loosely adherent cells were col-
lected, washed, reseeded at a concentration of 2  105 cells/well in me-
dium without antibiotics, and rested overnight.
Peritonealmacrophageswere isolated as previously described (30) and
seeded at 2 105 cells/well in medium containing no antibiotics.
Immortalized bonemarrow-derivedmacrophages (iBMMs) stably ex-
pressing enhanced GFP-LC3 (GFP-LC3) (31) were cultured in complete
RPMI (cRPMI) medium under constant selection with 10 g/ml puro-
mycin. Cells were seeded at 1  106 cells/well on poly-L-lysine-coated
19-mm coverslips in 12-well plates.
Infection of phagocytes. Cells were infected with live S. aureus bacte-
ria at amultiplicity of infection (MOI) of 10 or 100 for the indicated times.
In some cases, prior to infection, cells were incubated with 10 mM
3-methyladenine (3-MA; Sigma) for 30 min. At 2 h postinfection, me-
dium was replaced with fresh medium containing gentamicin (200 g/
ml) for 1 h to kill extracellular bacteria. This medium was replaced with
fresh medium containing no antibiotics, and this was considered time
zero (T0).
For assessment of total killing, cells were infected with live S. aureus
bacteria at an MOI of 10 or 100 for the indicated times and were not
treated with gentamicin.
Assessment of bacterial killing.At the indicated time points, infected
cells were spun down, the supernatant was removed, and cells were lysed
by the addition of 20 l 0.1% Triton X-100. The supernatant was then
reintroduced into the well and mixed with the cell lysate. Serial dilutions
of the suspension were prepared in PBS and plated onto tryptic soy agar
(TSA) to determine the number of CFU/milliliter. Bacterial killing was
determined as the percent reduction in the number of CFU in wells con-
taining bacteria and phagocytes compared to the number of CFU in wells
containing bacteria only.
Assessment of bacterial escape. S. aureus-infected BMDCs under-
went gentamicin treatment as described above. At specific time points, the
cell-free supernatants were collected, serially diluted in PBS, and plated
onto TSA to determine the number of bacteria that had escaped into the
medium, measured as the fold increase in log CFU/well from time zero.
Cell viability assays.To assess S. aureus-induced cytotoxicity, BMDCs
were infected and treated with gentamicin as described above. Lactate
dehydrogenase (LDH) release was measured by using the Pierce LDH
cytotoxicity assay kit (Thermo Scientific) according to themanufacturer’s
instructions. In some cases, cell viability was assessed by the addition of
propidium iodine (PI) (1g/ml; eBioscience) and analysis by flow cytom-
etry.
Vesicle lysis test. Phospholipid vesicles were prepared as described
previously (32). A vesicle lysis test (VLT) was performed by using a 1:1
ratio of the bacterial supernatant (cultures grown for 18 h) and pure
vesicles, and fluorescence intensity was measured at excitation and emis-
sion wavelengths of 485 and 520 nm, respectively, on a FLUOstar fluo-
rometer (BMGLabtech). Positive and negative controls were pure vesicles
with 0.01% Triton X-100 and HEPES buffer, respectively.
Measurement of RNAIII expression by reverse transcription-quan-
titative PCR. S. aureus RNA was isolated by using the RNeasy minikit
(Qiagen) according to the manufacturer’s instructions, with the addition
of TurboDNase (Ambion) after the purification step. RNAwas quantified
by using the RNAbroad-range kit (Qubit), and reverse transcription (RT)
was performed by using the ProtoScript Taq RT-PCR kit (New England
BioLabs) according to the manufacturer’s instructions, using random
primers. Standard curves were generated for both gyrase B (gyrFW [5=-C
CAGGTAAATTAGCCGATTGC-3=] and gyrRV [5=-AAATCGCCTGCG
TTCTAGAG]) and RNAIII (rnaIIIFW [5=-GAAGGAGTGATTTCAATG
GCACAAG-3=] and rnaIIIRV [5=-GAAAGTAATTAATTATTCATCTTA
TTTTTTAGTGAATTTG-3=]) primers, using genomicDNA todetermine
primer efficiency. Real-time PCR was performed by using SYBR green
PCR master mix (Applied Biosystems) as previously described (32).
Western immunoblotting. To detect LC3, BMDCs were infected and
treated with gentamicin as described above. At the specified time points,
BMDCswere lysed inNP-40 lysis buffer. The protein concentration of the
lysates was measured by using a Bradford assay (Thermo Scientific), and
equal concentrations of protein were loaded into each lane of the gel.
Samples were separated on a 15%SDS-polyacrylamide gel and transferred
onto a polyvinylidene difluoride (PVDF) membrane. The membrane was
blocked with 5% (wt/vol) milk before being probed with antibody (rabbit
anti-LC3 at 1:1,000 [Cell Signaling] and horseradish peroxidase [HRP]-
conjugated goat anti-rabbit immunoglobulin G [IgG] at 1:10,000 [Jack-
son Immune]). The membrane was developed with enhanced chemilu-
minescence (ECL) (Mybio) on a Bio-Rad GelDoc system.
To detect Hla expression, proteins from the filtered bacterial superna-
tant were concentrated by trichloroacetic acid precipitation, separated on
a 12.5% SDS-polyacrylamide gel, and transferred onto a PVDF mem-
brane. Themembrane was blocked in 10% (wt/vol) milk and probed with
polyclonal rabbit anti-Hla IgG (1:1,000) (33), followed by HRP-conju-
gated protein A (Sigma). Reactive bands were visualized by using the
LumiGLO reagent and peroxide detection system (Cell Signaling Tech-
nology).
Confocal imaging.BMDCswere infected and treatedwith gentamicin
as described above, and monodansylcadaverine (MDC) (50 M) was
added 15 min prior to cell fixation. Cells were then fixed in 2% parafor-
maldehyde (PFA; ThermoScientific). Alternatively, GFP-positive (GFP)
LC3 BMMswere infected and treatedwith gentamicin as described above.
At specific time points postinfection, cells were fixed in 2% PFA and
permeabilized in Triton X-100 (0.1% in PBS). Nonspecific binding was
blocked by incubation in 5% bovine serum albumin (BSA) before cells
were incubated with Alexa Fluor 555-conjugated phalloidin (1:100; Life
Technologies) for 1 h to stain actin.
The coverslips were mounted onto glass slides with fluorescent
mounting medium (DakoCytomation) and analyzed with an Olympus
FV1000 confocal laser scanning microscope.
In vivo intraperitoneal infection model. Mice were infected with S.
aureus (5 108 CFU) via intraperitoneal (i.p.) injection. At specific time
points postinfection, peritoneal exudate cells (PECs) were isolated by la-
vage of the peritoneal cavity with sterile PBS. Lavage fluid was serially
diluted in PBS and plated onto TSA to determine the bacterial burden at
the site of infection. Spleens were isolated and homogenized in 2 ml of
sterile PBS. Tissue homogenates were then serially diluted in PBS and
plated onto TSA to determine the tissue bacterial burden. Blood was col-
lected by cardiac puncture with a 27-gauge needle and a heparinized 1-ml
syringe. TheCFU/milliliter of bloodwas determined by serial dilution and
plating onto TSA plates.
To isolate leukocytes, blood was layered onto Histopaque-1083
(Sigma) for density gradient centrifugation. Leukocytes were collected
between the plasma layer and the pellet containing red blood cells (RBCs)
and extracellular bacteria (34). Isolated leukocytes were then washed well
and resuspended in Fc block for flow cytometric analysis or lysed in
sterile water to quantify cell-associated CFU.
Flow cytometry. PECs or blood leukocytes were blocked in Fc block
(1 g/ml; eBioscience) and then surface stained with fluorochrome-con-
jugated antibodies against Ly6G (clone 1A8; BDBioscience), F4/80 (clone
BM8; eBioscience), CD11c (clone N418; eBioscience), and CD11b (clone
M1/70; eBioscience). Flow cytometric data were acquired with a BD
FACSCanto II instrument (BD Biosciences) and analyzed using FlowJo
software (Tree Star).
To assess the rate of S. aureus phagocytosis by BMDCs, cells that had
been infectedwithCTV-labeled S. aureus for 30min or 2 hwere incubated
with gentamicin (200 g/ml) for 1 h, washed, and fixed in 2% PFA. The
S. aureus and Autophagy
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cells were then analyzed onBDFACSCanto II by gating on forward scatter
and side scatter, and the percentage of CTV cells was assessed.
Statistical analysis. Statistical analysis was carried out using Graph-
Pad Prism statistical analysis software. Differences between groups were
analyzed by the unpaired Student t test or analysis of variance (ANOVA)
with the appropriate posttest and by using repeated measures where re-
quired. A P value of	0.05 was considered statistically significant.
RESULTS
Killing of S. aureus by dendritic cells andmacrophages is strain
dependent. Despite the fact that dendritic cells have been shown
to be involved in coordinating the immune response to S. aureus
infection, their contribution to direct bacterial killing remains to
be fully established (35, 36). We compared the bactericidal capac-
ities of these phagocytic cells to those of macrophages, which have
a more clearly defined role in direct killing of S. aureus (37). Pri-
mary BMDCs were infected with two laboratory strains of S. au-
reus at an MOI of 10 (Fig. 1A) and an MOI of 100 (Fig. 1B), and
bacterial killing wasmonitored over time.Within 6 h of infection,

70% of SH1000 cells were killed, and by 16 h, almost 100% of
SH1000 cells had been killed by the BMDCs at either MOI. In
contrast, the BMDCs were unable to kill S. aureus strain PS80.
Interestingly, the ability of BMDCs to kill SH1000 appeared to
be MOI dependent. It was reported previously that BMDCs were
unable to kill SH1000 at an MOI of 0.1 (35). We also failed to
detect any killing of SH1000 cells by BMDCs at this lowMOI, but
the ability of BMDCs to kill SH1000 cells by 16 h became apparent
at MOIs of as low as 2 (97.7% 1.7% killing).
To establish if the inability to kill S. aureus strain PS80 was
specific to dendritic cells, we infected primary peritoneal macro-
phages with both strains of S. aureus at an MOI of 100. Similar to
the killing observed with BMDCs, peritoneal macrophages effi-
ciently killed SH1000 but were unable to kill PS80 (Fig. 1C). In-
terestingly, in our hands, BMDCs and macrophages demon-
strated similar capacities to kill S. aureus strain SH1000 (the
percent killing at 16 h was 90% 6.8% in BMDCs, compared to
78.3%  6.6% in macrophages). Taken together, these results
suggest that BMDCs are capable of killing S. aureus but that strain-
dependent differences may impact the ability of both macro-
phages and BMDCs to kill the bacterium.
S. aureus strain PS80 but not strain SH1000 can escape from
dendritic cells, causing associated cytotoxicity. Given that
BMDCs had different capacities to kill S. aureus strains PS80 and
SH1000, we wanted to confirm that both strains were phagocyto-
sed by BMDCs at the same rate. BMDCs were infected with CTV-
labeled S. aureus at anMOI of 100, and the uptake of bacteria into
BMDCs was assessed after 30 min and 2 h, following gentamicin
treatment to kill any bacteria that had not been phagocytosed. At
30 min postinfection, PS80 and SH1000 were phagocytosed by
BMDCs to the same extent, with
30% of BMDCs staining pos-
itively for CTV-labeled PS80 or SH1000 (Fig. 2A). At 2 h postin-
fection, the percentage of cells that were PS80-CTV increased,
alluding to the survival of this strain inside the cells.
S. aureus strains SH1000 and PS80 were both phagocytosed by
BMDCs to the same extent, but following phagocytosis, PS80 was
not killed. To establish whether PS80 escaped from the BMDCs,
cells were allowed to phagocytose the bacteria, and any extracel-
lular bacteria were killed by the addition of the bactericidal anti-
biotic gentamicin. Cells were washed and incubated in fresh me-
dium, and the escape of viable bacteria into the supernatant was
measured after 6 and 12 h of incubation. By 6 h, therewas evidence
of PS80 but not SH1000 escaping from the BMDCs. By 12 h, the
level of PS80 in the cell culture supernatant was significantly
higher than that of SH1000 (Fig. 2B). Similar results were ob-
tained following infection at an MOI of 10 (data not shown).
To establish if the escape of S. aureus from BMDCs was asso-
ciated with cytotoxicity, LDH release from the infected BMDCs
was measured. LDH activities were similar in uninfected BMDCs
and BMDCs infected with SH1000 at both 6 h and 12 h postinfec-
tion, indicating that SH1000 had no effect on the viability of the
infected cells. In contrast, BMDCs infected with PS80 had signif-
icantly higher levels of LDH in the supernatant than did BMDCs
infected with SH1000 or uninfected BMDCs at both time points
(Fig. 2C), indicating significant cytotoxicity.
Identification of S. aureus bloodstream infection isolates
with the ability to escape phagocytic killing. S. aureus PS80 and
SH1000 are both well-characterized laboratory strains. However,
their relevance to clinical isolates may be limited. Accordingly,
isolates that were recovered from S. aureus bacteremia patients
were collected and screened for cytotoxic effects. BMDCs were
infected with each isolate at anMOI of 100, and the viability of the
infected DCs was assessed after 24 h by staining with PI. The clin-
ical isolates clustered together into one group that was cytotoxic to
BMDCs, similarly to PS80; a second group that did not exert any
FIG 1 Killing of S. aureus by dendritic cells and macrophages is strain dependent. (A and B) BMDCs were infected with PS80 or SH1000 at anMOI of 10 (A) or
100 (B). (C)Alternatively, peritonealmacrophageswere infectedwith either strain at anMOIof 100. The percent killing of bacteriawas determined by comparing
the number of total CFU in the presence of phagocytes to the number of CFU in medium only. Results are expressed as means standard errors of the means
for each time point (n 3 to 4). *, P	 0.05; ***, P	 0.001 (compared to other strains, as determined by repeated-measures two-way ANOVAwith a Bonferroni
posttest).
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cytotoxic effects, akin to SH1000; and a third, intermediate group
(Fig. 3A).
Representative isolates from both the “PS80-like” group and
the “SH1000-like” group were selected for analysis, S. aureus 68
(Sa68) and S. aureus 279 (Sa279). BMDCswere infected with Sa68
or Sa279 at an MOI of 100. The BMDCs were capable of killing
strain Sa279 but were unable to kill strain Sa68 (Fig. 3B). These
data suggest that Sa68 is similar to PS80 and may be capable of
escaping from phagocytes. We confirmed that both strains were
phagocytosed by BMDCs at similar rates by labeling the bacteria
with CTV and infecting BMDCs as described above. Similar to the
uptake of PS80 and SH1000, 
30% of BMDCs were associated
with CTV Sa279 or Sa68 by 30 min postinfection (Fig. 3C). We
then assessed the ability of Sa68 to escape from BMDCs. After 12
h, the level of Sa68 in the cell culture supernatant was significantly
higher than that of Sa279 (Fig. 3D).
To establish if the ability of Sa68 to escape from BMDCs cor-
related with cytotoxicity, cells were infected with Sa68 or Sa279 or
were left uninfected. Following gentamicin killing of extracellular
nonphagocytosed bacteria, LDH release was monitored at 6 h and
12 h. The level of cytotoxicity (LDH release) associated with Sa68-
infected cells was significantly higher than that associated with
Sa279-infected cells or uninfected control cells (Fig. 3E).
Infection with PS80, but not SH1000, is associated with in-
creased accumulation of LC3-II autophagosomes. S. aureus
was previously shown to associate with autophagosomes in non-
professional phagocytic cells. This provides a niche for the intra-
cellular survival of S. aureus, where it can replicate and eventually
escape into the cytoplasm, ultimately leading to host cell death
(23, 38). We postulated that S. aureus strain PS80 might employ a
similar mechanism in BMDCs to evade killing. To assess au-
tophagy in BMDCs, cells were infected, and lysates were prepared
at intervals up to 6 h postinfection, with gentamicin killing of
extracellular bacteria. Processing of the autophagic marker LC3
was then assessed by Western immunoblotting (39). Infection of
BMDCs with S. aureus strain PS80 resulted in the persistence of
substantial levels of LC3-II for at least 6 h. In comparison, unin-
fected BMDCs or BMDCs infected with SH1000 showed no accu-
mulation of LC3 autophagosomes, although there was persis-
tently a low level of LC3-II processing, which was presumably due
to homeostatic autophagy, followed by autosome-lysosome fu-
sion and degradation of LC3 (Fig. 4A).
To confirm that PS80 was associating with autophagosomes,
BMDCs were infected with CTV-labeled S. aureus strain PS80 or
SH1000 and then treated with gentamicin to kill any extracellular
bacteria. Staining with MDC (a fluorescent compound which ac-
cumulates specifically in autophagic vacuoles [40]) revealed colo-
calization between PS80 and the autophagosome. SH1000was not
seen to colocalize to the same extent (Fig. 4B). Additionally, RAW
264 macrophages that had been stably transfected with GFP-LC3
(31) were infected and treated with gentamicin as described
above. Again, CTV-labeled PS80 was seen to colocalize with
GFP-LC3 punctae at 3 h postinfection. In comparison, SH1000
did not show the same level of association with GFP-LC3 punc-
tae (Fig. 4C).
To confirm that clinical isolates could also manipulate the au-
tophagic process, BMDCs were infected with Sa68 or Sa279, and
lysates were prepared after 6 h. Processing of LC3 was assessed by
Western immunoblotting. Similarly to PS80, Sa68-infected cells
had considerable levels of LC3-II present, indicating a delay in the
degradation of the autophagosomes. In addition, the level of
LC3-II in Sa279-infected cells was similar to that in SH1000-in-
fected cells or uninfected BMDCs, suggesting that these cells had
normal autophagic flux (Fig. 5A).
FIG 2 S. aureus strain PS80 but not SH1000 can escape from dendritic cells, causing associated cytotoxicity. (A) BMDCs were infected with either CTV-labeled
PS80 or SH1000 at anMOI of 100. The percent uptake of bacteria was measured at 30 min or 2 h. (B) Following infection of BMDCs with PS80 or SH1000 at an
MOI of 100, the escape of each strain into the cell culturemediumwas assessed at 6 h and 12 h. (C) LDH levels in the supernatants of both infected and uninfected
BMDCs were assessed. Results are expressed as means standard errors of the means (A and B) or means standard deviations (C) (n 3 to 4 [A and B]; data
in panel C are representative of data from 3 independent experiments). *, P	 0.05; ***, P	 0.001; n.s., not significant (as determined by repeated-measures one-
or two-way ANOVA with the appropriate posttest).
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Engagement of autophagosomes facilitates escape of S. au-
reus from phagocytes. To ascertain if the delay in the turnover of
autophagosomeswas associatedwith the ability of S. aureus strains
PS80 and Sa68 to escape phagocyte killing, BMDCs were pre-
treated with 3-methyladenine (3-MA), a well-established phos-
phatidylinositol 3-kinase (PI3K) inhibitor that inhibits the induc-
tion of autophagy (42), prior to infection with these two strains.
The escape of S. aureus into the supernatant was then assessed at 6
and 12 h. In the presence of 3-MA, the escape of PS80 and Sa68
into the cell culture supernatant was completely inhibited (Fig.
5B). Associated with this, 3-MA treatment restored the viability of
the infected BMDCs, with the level of LDH activity in the culture
supernatant being significantly reduced following infection with
both PS80 and Sa68 (Fig. 5C). Importantly, 3-MA had no direct
effect on bacterial viability after 18 h of incubation (7.90  0.13
versus 7.55 0.39 log CFU/ml for S. aureus alone versus S. aureus
plus 3-MA).
Differential expression of Agr by S. aureus strains correlates
with their ability to engage autophagosomes. It was previously
shown that the ability of S. aureus to divert from the endosomal
pathway to autophagosomes is driven by factors that are under the
control of the Agr regulatory system (23). We hypothesized that
the different abilities of strains to delay autophagic flux may be
associated with the level of expression of Agr. Consequently, Agr
FIG 3 Identification of clinical bloodstream isolates with the ability to escape phagocytic killing. (A) BMDC viability was screened by PI staining at 24 h
postinfection with a panel of clinical strains, identifying PS80-like strains (black bars), SH1000-like strains (white bars), and “intermediate” strains (checkered
bars). (B) BMDCs were infected with Sa68 or Sa279, and the percent killing of bacteria was determined by comparing the number of total CFU in the presence
of phagocytes to the number of CFU inmediumonly. (C) BMDCswere infected with either CTV-labeled Sa68 or Sa279 at anMOI of 100, and the percent uptake
of each strain was determined by flow cytometry at 30 min or 2 h postinfection. (D) Following infection of BMDCs with Sa68 or Sa279 at an MOI of 100, the
escape of each strain into the cell culture medium was assessed at 6 h and 12 h. (E) LDH levels in the supernatants of both infected and uninfected BMDCs
were assessed. Results are expressed as means  standard errors of the means (A to D) or means  standard deviations (E) (n  2 to 6 [A to D]; data in
panel E are representative of data from 3 independent experiments). *, P 	 0.05; ***, P 	 0.001 (as determined by repeated-measures one- or two-way
ANOVA with the appropriate posttest).
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activity wasmeasured by using a vesicle lysis test (VLT). This assay
measures the interaction of PSM toxins with lipid vesicles (32).
The PSM peptide delta-toxin is translated from a short open
reading frame located within the regulatory RNAIII molecule,
while transcription of the other psm genes is activated directly by
the AgrA response regulator of the Agr two-component signal
transduction system that responds to high cell density. Expression
of these membrane-damaging toxins is a direct manifestation of
the level of expression of Agr in the stationary phase of growth
(43). S. aureus strains PS80 and Sa68 induced significantly more
vesicle lysis than did SH1000 and Sa279 (Fig. 6A), suggesting a
higher level of Agr activity in these strains. To further assess the
expression ofAgr, theRNAIII level wasmeasured. Consistentwith
data from the VLT, RNAIII was expressed at higher levels by S.
aureus strains PS80 and Sa68 than by SH1000 and Sa279 (Fig. 6B).
Taken together, we can conclude that S. aureus strains PS80 and
Sa68, which induce autophagosome accumulation, exhibit a
higher level of Agr activity than do SH1000 and Sa279, which have
no effect on autophagosomes.
Deletion of the agr locus prevents LC3-II accumulation and
facilitates bacterial killing. In order to investigate if strain-depen-
dent differences in bacterial killing and the delay of normal au-
tophagic flux were under the control of Agr-regulated genes, we
generated an agrmutant strain of PS80 by allelic exchange. BMDCs
were infected with PS80 and PS80agr, and bacterial killing was
monitored over time. By 6 h postinfection, almost 100% of
PS80agr bacteria were killed (Fig. 7A), compared to the parental
strain, which failed to be killed. Furthermore, the escape of PS80
FIG 4 S. aureus strain PS80 inhibits normal autophagic flux in phagocytes. (A) BMDCswere infected with S. aureus strain PS80 or SH1000. At the indicated time
points, cells were lysed, and expression of LC3was analyzed byWestern immunoblotting. Bands show the conversion of LC3-I to LC3-II. The level of-actin was
measured as a loading control. Representative blots from 3 independent experiments are shown. (B) Six hours after infectionwith CTV-labeled bacteria, BMDCs
were stained with MDC and fixed to be viewed under a fluorescence microscope. Blue, bacteria; yellow, MDC. White arrows indicate colocalization of bacteria
and LC3-II. (C) Three hours after infection with CTV-labeled bacteria, GFP-LC3 iBMMs were fixed, permeabilized, and stained with phalloidin for viewing
under a fluorescence microscope. Blue, bacteria; green, LC3; red, phalloidin. White arrows indicate colocalization of bacteria and LC3-II. See also the enlarged
images, which show the extent of colocalization.
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from BMDCs was significantly inhibited in the absence of agr
(1.29 0.28-fold increase in logCFU/well compared to PS80 atT0
versus 0.52  0.12-fold reduction in log CFU/well compared to
PS80agr at T0) at 12 h postinfection.
In addition, the accumulation of LC3-II in infected BMDCs
was also measured after 6 h of infection with PS80 or PS80agr.
LC3-II expression was reduced in cells infected with PS80agr
compared to the wild type, further proving that the agr locus plays
a role in the ability of PS80 to block autophagic flux. However,
LC3-II processing was not reduced to baseline levels (Fig. 7B),
suggesting that PS80 may be expressing alternative, non-Agr-reg-
ulated genes, which have some capacity to delay autophagic flux.
Agr influences S. aureus persistence in vivo. Having estab-
lished that both laboratory and clinical strains of S. aureus can
subvert autophagy to evade phagocytic killing, it was important to
determine whether this phenomenon affected infection outcomes
in vivo. Groups of wild-type mice were infected with S. aureus
strain PS80, SH1000, Sa68, Sa279, or PS80agrby i.p. injection. At
FIG 5 Inhibition of autophagic flux facilitates escape of S. aureus from phagocytes. (A) BMDCs were infected with S. aureus strains PS80, SH1000, Sa68, and
Sa279. At 6 h, cells were lysed, and expression of LC3 was analyzed by Western immunoblotting. Bands show the conversion of LC3-I to LC3-II. The level of
-actin was measured as a loading control. A representative blot is shown. (B) BMDCs were pretreated with 3-MA for 30 min and infected with either PS80 or
Sa68 (MOI of 100). The escape of each strain into the cell culture medium was assessed at 6 h and 12 h. (C) LDH levels in the supernatants of 3-MA-pretreated
and untreated BMDCs that were infected with either PS80 or Sa68 were assessed. Results are expressed as means standard errors of the means (A and B) or
means standard deviations (C) (n 4 to 6 [A andB]; data in panel C are representative of data from3 independent experiments). ***,P	 0.001 (as determined
by repeated-measures two-way ANOVA with a Bonferroni posttest).
FIG 6 S. aureus strains exhibit distinct levels of Agr activity, as assessed by VLT and RNAIII gene expression. (A) The bacterial supernatant was incubated with
lipid vesicles at a 1:1 ratio, and the fluorescence intensity was recorded as a measure of vesicle lysis. (B) RNAIII activity was measured by using quantitative
RT-PCR, as a ratio of RNAIII to gyrB transcript numbers. Results are expressed as means standard errors of the means (n 3 to 4). *, P	 0.05; **, P	 0.01;
***, P	 0.001 (as determined by one-way ANOVA with a Tukey posttest).
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3 h postchallenge, blood was collected, and the total bacterial bur-
den in the blood was quantified (Table 2). As expected, there were
significant differences in the bacterial burdens in the blood follow-
ing infection with different strains. It was previously documented
that strains of S. aureus expressing capsular polysaccharide (CP)
seed the bloodstream from the peritoneal cavity in larger numbers
than do acapsular strains (44, 45). PS80 is known to express CP8
(24), SH1000 and PS80agr are acapsular (25, 46), and the CP
expression of the clinical strains is unknown. In order to prove
that the differential abilities of these strains to seed the blood were
not simply due to differences in CP expression levels, mice were
infected with PS80 or an isogenic mutant of PS80, RMS-1, that is
acapsular (45). At 3 h postinfection, blood was isolated, and the
total bacterial burden was quantified. There was no significant
difference in the levels of bacteria recoverable from the blood be-
tween the two groups (4.0 0.2 versus 3.7 0.1 log CFU/ml fo r
PS80 versus RMS-1), confirming that the observed differences in
bacteremia levels were not a result of differential CP expression.
To prove that differences in bacterial burden in the blood were
due to the differential abilities of individual strains to survive in-
tracellularly, mice were infected with S. aureus strain PS80,
SH1000, PS80agr, Sa68, or Sa279. At 3 h postinfection, the total
leukocytes were separated from the RBCs and extracellular bacte-
ria by centrifugation on Histopaque-1083. Leukocytes were then
washed thoroughly and lysed to quantify viable intracellular S.
aureus bacteria. The number of intracellular bacteria recovered
was significantly higher in PS80-infected animals than in
PS80agr-infected (Fig. 8A) or SH1000-infected (Fig. 8B) ani-
mals. The same trend was seen for the clinical strains, with signif-
icantly higher levels of Sa68 being recovered from the blood leu-
kocytes than Sa279 (Fig. 8C). This suggests that PS80 and Sa68 are
capable of surviving within phagocytes in vivo, potentially facili-
tating systemic dissemination and persistence. Consistent with
this, animals infected with PS80 demonstrated a significantly in-
creased bacterial burden in the spleen at 12 h postchallenge com-
pared to animals infected with PS80agr (Fig. 8D) or SH1000
(Fig. 8E). Unfortunately, due to limitations in cell numbers, we
were unable to analyze autophagic flux in individual blood leuko-
cyte populations ex vivo.
Finally, to establish which specific leukocyte populations in the
blood were harboring intracellular S. aureus, GFP-expressing
PS80 was injected into the peritoneum. At 3 h postinfection, total
leukocytes were isolated from the blood. These leukocytes were
stained with a panel of antibodies against various surface markers
in order to identify the phagocyte populations containing intra-
cellular bacteria. As expected, the predominant cell type associ-
ated with GFP-expressing PS80 was found to be polymorphonu-
clear leukocytes (PMNs). Surprisingly, DCs accounted for the cell
type that contained the second largest population of PS80-GFP
cells. In contrast, only a low number of monocytes was associated
with PS80-GFP (Fig. 8F). This supports the contention of this
study that DCs play an important direct role in the phagocytosis
and clearance of S. aureus.
DISCUSSION
Undoubtedly, the success of S. aureus as a pathogen can be attrib-
uted to its inherent ability to disarm the host’s protective immune
responses. In particular, S. aureus possesses a unique arsenal of
virulence factors that can circumvent the bactericidal effects of
phagocytes and canmanipulate these cells, even parasitizing them
to facilitate an intracellular lifestyle. Here we provide significant
new insights into themolecular mechanisms involved. Analysis of
several S. aureus strains revealed that despite being phagocytosed
to similar extents, some strains could elude phagocytic killing,
subsequently lysing phagocytes and escaping. The ability to evade
killing was directly associated with the capacity of these strains to
inhibit normal autophagic flux within the cells. We showed that
the ability of S. aureus to subvert autophagic pathways and survive
within phagocytes is associated with Agr activity, as strains with
lower levels of Agr exhibited normal, homeostatic turnover of
autophagosomes. Moreover, we established that the level of Agr
FIG 7 PS80agr is killed by BMDCs and leads to reduced accumulation of LC3-II. (A) BMDCs were infected with S. aureus strain PS80 or PS80agr at anMOI
of 100. The percent killing of bacteria was determined by comparing the number of total CFU in the presence of BMDCs to the number of CFU inmedium only.
(B) At 6 h, cells were lysed, and expression of LC3 was analyzed byWestern immunoblotting. The level of -actin was measured as a loading control. Results are
expressed asmeans standard errors of themeans (n 3 [A]; data in panel B are representative of data from 3 individual experiments). *, P	 0.05; **, P	 0.01;
***, P	 0.001 (as determined by repeated-measures two-way ANOVA with a Bonferroni posttest).
TABLE 2 Bacterial burden in blood
Strain
Mean log CFU/ml
SEM
P value compared
to PS80a
PS80 3.63 0.12 NS
SH1000 2.93 0.26 	0.01**
Sa68 3.92 0.39 NS
Sa279 2.37 0.49 	0.001***
PS80agr 2.28 0.29 	0.0001***
a NS, not significant.
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expression is directly linked with the ability of S. aureus to survive
intracellularly within phagocytes in vivo, suggesting that this phe-
nomenon is related to the ability of S. aureus to subvert autophagy.
Previous studies have documented a protective role for den-
dritic cells during S. aureus infection. Depletion of dendritic cells
was associated with increased mortality during S. aureus blood-
stream infection (35) and impaired bacterial clearance in an S.
aureus pneumoniamodel (36). In both cases, the beneficial effects
afforded by dendritic cells were dependent upon their ability to
control the inflammatory response. In this study, we demon-
strated for the first time that dendritic cells also have the potential
to contribute to host protection by directly killing S. aureus. The
bactericidal effects of dendritic cells were found to be comparable
to those of macrophages, with both cell types being effective in
reducing the growth of S. aureus strain SH1000. Consequently, we
chose DCs as representative phagocytes to investigate the mecha-
nisms by which S. aureus can parasitize these cells. Of note, our
findings contrasted with those of a previously reported study,
which concluded that BMDCs do not play a major role in direct
killing of S. aureus (35). In that study, dendritic cells were infected
with S. aureus at a very low ratio (MOI of 0.1). Given that the
uptake of bacteria by macrophages has been directly linked to the
MOI (47), we hypothesized that bacteria must reach a critical
threshold to ensure appropriate activation of the phagocytes be-
fore phagocytic killing can occur. To test this, dendritic cell killing
assays were repeated by using SH1000 at an MOI of 0.1, and no
killing was observed. However, the ability of BMDCs to kill
SH1000 by 16 h became apparent atMOIs of as low as 2 (97.7%
1.7% killing).
Our previouswork demonstrated that S. aureus strains SH1000
and PS80 possess distinct capacities to activate innate signaling
pathways in dendritic cells, resulting in different levels of interleu-
kin-1 (IL-1) production (48). Accordingly, we wanted to dis-
sect the interaction of these particular strains with dendritic cells.
Interestingly, while both primary BMDCs and peritoneal macro-
phages were able to kill S. aureus strain SH1000, they lacked the
ability to kill PS80. PS80 avoided the bactericidal effects of phago-
cytes and instead escaped from the cells by inducing cell death. In
contrast, once phagocytosed, SH1000 did not escape from the
phagocyte, and cells that ingested this strain remained viable for
up to 24 h postinfection. Importantly, both strains of S. aureus
were efficiently phagocytosed by dendritic cells, implying thatma-
nipulation of the phagocyte response by PS80 was exerted once it
became intracellular.
S. aureus strain PS80 was previously shown to survive intracel-
lularly within neutrophils isolated from S. aureus surgical site in-
fections (49).We have now demonstrated that PS80 establishes its
intracellular survival niche within phagocytes through subversion
of the autophagic pathway. Following infection of BMDCs, PS80
prevented the constitutive degradation of autophagosomes by
lysosomes, leading to the accumulation of LC3-II. In contrast, S.
aureus strain SH1000 did not interfere with the homeostatic turn-
over of the autophagicmachinery. Furthermore, BMDCs that had
been treated with MDC (which accumulates in the autophago-
some) postinfection showed colocalization between the autopha-
gosome and PS80 but not SH1000. In addition, macrophages that
were stably transfected with GFP-LC3 also demonstrated colocal-
ization of PS80 with LC3-II punctae, indicating the interaction of
the bacterium with autophagosomes. Upon invasion of nonpro-
fessional phagocytes, S. aureus was shown to subvert autophagy,
FIG 8 Intracellular persistence of S. aureus facilitates infection in vivo. Groups of mice were challenged with S. aureus strain PS80 (A, B, D, and E), PS80agr (A
andD), SH1000 (B and E), Sa68 (C), Sa279 (C), or GFP-PS80 (F) (5 108 CFU) via the intraperitoneal route. (A to C) At 3 h postchallenge, blood was collected,
and total leukocytes were isolated, washed, and lysed. Numbers of cell-associated bacteria per 105 cells are shown. (D and E) At 12 h postchallenge, spleens were
isolated and homogenized, and the bacterial burdenwas assessed. (F) Leukocytes isolated at 3 h postchallengewere also analyzed by flow cytometry, andCD11b
F480 Ly6G (neutrophils [PMNs]), CD11c (DCs), and CD11b F480 Ly6G (monocytes [M]) populations that were GFP were determined. Results
expressed as means standard errors of the means; the lines indicate the means (n 5 to 12). *, P	 0.05; **, P	 0.01 (as determined by an unpaired Student
t test or one-way ANOVA with a Tukey posttest).
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enabling replication within the autophagosome and subsequent
lysis of the host cell (23). Consistent with this, we have demon-
strated that the cytotoxic effects exerted by S. aureus strain PS80
on BMDCs are associated with the subversion of autophagy.
Treatment of BMDCs with the autophagy inhibitor 3-MA pro-
tected cells from PS80-induced cytotoxicity and simultaneously
prevented the escape of the bacterium from the phagocyte.
Importantly, bloodstream infection isolates with phenotypes
comparable to those of PS80 and SH1000 were identified, high-
lighting the clinical relevance of this phagocyte evasion strategy
for facilitating systemic infection. Similarly to PS80, Sa68 was not
killed by BMDCs and could escape from the cells, causing associ-
ated cytotoxicity. In contrast, Sa279 behaved more like SH1000
and was killed by BMDCs. This was consistent with the obser-
vation that Sa68 induced significant LC3-II accumulation in
BMDCs, while inhibition of autophagy by using 3-MA reduced
the escape of Sa68 from BMDCs.
The ability of S. aureus to subvert autophagy in nonphagocytic
cells is controlled by the Agr system and has been shown to spe-
cifically depend upon Agr-regulated expression of alpha-toxin
(Hla) (23, 38). In vitro, agr and hla mutants of S. aureus fail to
trigger autophagy; are delivered efficiently to the lysosome, where
they are degraded; and thus cannot survive intracellularly for ex-
tended periods. However, a recently reported in vivo study has
shown that while autophagy plays an important role in conferring
protection against S. aureus lethality bymediating tolerance to the
cytotoxic effects of Hla, infection with an Hla mutant strain actu-
ally caused increased bacterial burdens in wild-type mice in com-
parison to Atg16L1HM mice (which display reduced autophagy).
This indicates that Hla may actually be dispensable in the exploi-
tation of autophagy in the context of intracellular bacterial sur-
vival (50). Interestingly, when we profiled Hla expression among
our strains, it did not correlate with the abilities of these strains to
inhibit autophagic flux in phagocytes. S. aureus strains PS80 and
Sa68 were comparable in their abilities to manipulate autophagy
in order to evade phagocytic killing; however, PS80 was a high-
level Hla producer, whereas Sa68 was Hla negative. Furthermore,
both SH1000 and Sa279 are killed by DCs and fail to accumulate
autophagosomes, but SH1000 expresses low levels of Hla, and no
expression is detectable in Sa279 (see Fig. S1 in the supplemental
material). S. aureus strains PS80 and Sa68, which evade phagocytic
killing through the subversion of autophagy, express higher levels
of Agr RNAIII and membrane-damaging cytolytic peptide toxins
than do SH1000 and Sa279, which did not have any appreciable
effect on autophagy and were killed by the phagocytes. Crucially,
we have also shown that Agr activity dictated the ability of S. au-
reus to survive within phagocytes in vivo. Using an agr mutant of
PS80, we demonstrated a reduced ability of PS80agr to survive
within leukocytes isolated from peripheral blood following sys-
temic challenge compared to that of wild-type strain PS80. In
addition, SH1000 (which exhibited reduced Agr activity) also had
a significantly reduced capacity to survive within peripheral blood
leukocytes in vivo, confirming that the inability of PS80agr to
survive in the phagocytes is not an artifact of the mutation of agr.
Similarly, clinical strain Sa279 (which also exhibits reduced Agr
activity) shows significantly reduced survival in circulating leuko-
cytes in comparison to Sa68. It appears that the Agr-dependent
predilection of PS80 and Sa68 for associating with autophago-
somes enables them to survive within circulating leukocytes, thus
potentially increasing their capacity for systemic dissemination.
Consistent with this, bacterial burdens in the spleen were signifi-
cantly elevated in PS80-infected mice compared to those in the
spleen of animals infected with PS80agr or SH1000, suggesting
that intracellular survival in the autophagosome facilitates in-
creased persistence in the periphery of the host.
Until this study, Hla was the only known S. aureus virulence
factor implicated in the induction of autophagy (38). However,
the pattern of Hla expression among the strains used in this study
was not sufficient to explain the phenotypes observed, and it raises
the question of whether other Agr-regulated factors might also be
capable of manipulating autophagy. Intriguingly, the VLT used to
assess Agr activity measures PSM activity in culture supernatants
of S. aureus, and the pattern of vesicle lysis corresponds exactly
with the observed phenotypes (32). Thus, it is tempting to specu-
late that these toxins may also have an as-yet-undocumented role
in the induction of autophagy in phagocytic cells. Interestingly,
melittin, a component of bee sting venom that is an -helical,
amphipathic antimicrobial peptide, similar to delta-toxin (51),
was previously shown to induce autophagic cell death in trypano-
somes (52). In addition, PSMs trigger phagosomal escape by S.
aureus in the monocytic cell line THP-1s (16), allowing the bacte-
ria to replicate in the cytoplasm and leading to cell lysis (17).
Autophagy has been shown to respond to bacteria both in the
cytosol andwithin damaged phagosomes (53), supporting the no-
tion that certain strains of S. aureus deliberately induce autophagy
by causing damage to the phagosome. By inhibiting the digestion
of the autophagosomes by the lysosomes, they then survive within
autophagosomes. A comprehensive analysis of the role played by
PSMs in the induction of and engagement with autophagic path-
ways is warranted but is beyond the scope of the current study.
The precise mechanism by which S. aureus subverts autopha-
gosomes has yet to be defined. It was previously shown that au-
tophagosomesmay form around a phagosome that has been dam-
aged by internalized bacteria such as Salmonella enterica (54),
suggesting that both strains of S. aureus may be phagocytosed
normally but that PS80may then damage the phagosome deliber-
ately in order to secrete itself within an autophagosome. Alterna-
tively, Gresham et al. suggested that S. aureus can be taken up
unconventionally by neutrophils viamacropinocytosis into “large
spacious vacuoles” (5). Other studies have shown that autophagy
proteins can be recruited to single-membrane vacuoles such as
macropinosomes (55). This may suggest an alternative internal-
ization route for certain strains of S. aureus.While some strains are
phagocytosed and killed by phagolysosomal fusion, others may
become internalized via macropinocytosis, which facilitates the
subversion of autophagic pathways in order to promote their sur-
vival.
Interestingly, PS80 can survive within several different phago-
cytic cell types in vivo. Consistent with data from previous studies
(5, 49), we showed that neutrophils are the main intracellular
reservoir of S. aureus. However, DCs showed higher levels of via-
ble intracellular bacteria than did monocytes, further supporting
our belief that these cells are critical in regulating the outcomeof S.
aureus infection. The primary role of DCs is to migrate to the
lymph node following antigen uptake in order to activate the
adaptive immune response. Therefore, the ability to survive
within these cellsmay be an attractive route of dissemination for S.
aureus.
This study contributes to the growing literature that links the
subversion of autophagosomes by S. aureuswith intracellular sur-
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vival (23, 38). Our data demonstrate that S. aureus strain PS80 and
a comparable clinical isolate, which express high levels of Agr,
prevent constitutive degradation of LC3-II autophagosomes in
order to survive and escape killing by professional phagocytes.
Strains that had a lower level of Agr expression did not affect the
degradation of autophagosomes in BMDCs and were efficiently
killed. This study implicates autophagy as a mechanism to facili-
tate the temporary intracellular survival of certain S. aureus strains
within different phagocytes, maximizing their potential for dis-
semination and persistence in vivo.
The notion that S. aureus could parasitize neutrophils to facil-
itate dissemination has already been proposed (56), and our stud-
ies support the hypothesis that other phagocytes may also act as
“Trojan horses” for the metastasis of S. aureus, provided that the
infecting organism possesses the appropriate tools to subvert au-
tophagosomes. Given that our findings were replicated with clin-
ically relevant strains, it is tempting to speculate that identification
of S. aureus isolates that can inhibit autophagic flux by measuring
Agr activity may predict invasive disease potential.
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